Sold my large holding in a floundering Australian stem cell sector player in late June 16 & bought into msb. Touch wood a good move. Lucky timing & up over 50%!
The old coy still has no definitive efficacy for any product, not even Phase I safety results , chronic delays, appalling communications (google "mushroom shareholders"), amateur management, a declining SP & mkt cap & no real support or interest. Even after an apparently successful lifeline funding partnership the SP went nowhere but down.
msb is not perfect but by comparison its very good. Even without comparison 50% in 7 mos is nice
Keep it up!
Sold my large holding in a floundering Australian stem cell...
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.31 |
Change
0.040(3.16%) |
Mkt cap ! $1.490B | |||
| Open | High | Low | Value | Volume |
| $1.28 | $1.32 | $1.26 | $3.433M | 2.652M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 39558 | $1.30 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.31 | 21776 | 3 |
View Market Depth
| Last trade - 16.10pm 28/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |